2018
DOI: 10.1186/s13569-018-0096-8
|View full text |Cite
|
Sign up to set email alerts
|

Non-canonical WNT6/WNT10A signal factor expression in EBV+ post-transplant smooth muscle tumors

Abstract: Post-transplant smooth muscle tumors (PTSMTs) are rare mesenchymal neoplasms which occur after solid organ or haematopoietic stem cell transplantation. PTSMT typically consist of Epstein–Barr-virus (EBV)+ smooth muscle-like cells and show an intermediate malignancy. Their main occurrences are visceral organs, especially the liver, but intracranial appearances are described and associated with a poor prognosis. EBV drives the growth of PTSMT; however, the underlying molecular mechanisms still remain unclear. Ge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 30 publications
0
3
0
Order By: Relevance
“…Interestingly, WNT6 and WNT10A are located immediately adjacent to one another on chromosome 2 suggesting co-regulation of respective promotors (30), and co-expression has also been shown in the placenta (31). While typically related to canonical Wnt activation, their co-expression has also been linked to non-canonical Wnt signaling (32). FZD2 and FZD4 expression are restricted to villous mesenchymal cells, which are important in triggering trophoblast invasion (33).…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, WNT6 and WNT10A are located immediately adjacent to one another on chromosome 2 suggesting co-regulation of respective promotors (30), and co-expression has also been shown in the placenta (31). While typically related to canonical Wnt activation, their co-expression has also been linked to non-canonical Wnt signaling (32). FZD2 and FZD4 expression are restricted to villous mesenchymal cells, which are important in triggering trophoblast invasion (33).…”
Section: Discussionmentioning
confidence: 99%
“…It is noteworthy to mention that aberrant activation of Wnt signaling pathways is obviously not limited to the four cancer types mentioned below. Various Wnt ligands, the agonist Norrin, Fz receptors and the co-receptors Lrp6 and Ror1/2 have been reported to be abnormally expressed and associated with metastatic behavior, cancer progression and chemoresistance in ovarian cancer, glioblastoma multiforme, chronic lymphocytic leukemia, melanoma, multiple myeloma, post-transplant smooth muscle tumor, prostate cancer, pancreatic cancer gastric cancer, oral squamous cell carcinoma, Ewing sarcoma, osteosarcoma, and malignant peripheral nerve sheath tumors ( Derksen et al, 2004 ; Larue and Delmas, 2006 ; Dissanayake et al, 2007 ; Yan et al, 2016 ; Yu et al, 2016 ; Li et al, 2017 , 2019a ; Liu et al, 2017 ; Pridgeon et al, 2017 ; Sandsmark et al, 2017 ; Jiang et al, 2018 ; Sinnberg et al, 2018 ; Teiken et al, 2018 ; Yang et al, 2019b ; Chehover et al, 2020 ; El-Sehemy et al, 2020 ; Frenquelli et al, 2020 ; Kotrbova et al, 2020 ). Thus, a thorough understanding of misregulation of Wnt signaling pathways at the plasma membrane will pave the way for new therapeutic approaches for cancer.…”
Section: Misregulation Of Wnt Signaling Pathways At the Plasma Membramentioning
confidence: 99%
“…Wnt6, a member of the Wnt protein family, is always coexpressed with Wnt10a. These molecules are both highly expressed in carcinogenesis and cell proliferation [53]. Nevertheless, how Wnt6 is activated and further inhibits EZH2 after NOX4 overexpression remains unclear.…”
Section: Figmentioning
confidence: 99%